000			01885 a2200505 4500
005			20250513205618.0
264		0	_c20000420
008			200004s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/s0735-1097(00)00554-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aLincoff, A M
245	0	0	_aPlatelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cApr 2000
300			_a1103-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAbciximab
650	0	4	_aAcetates _xtherapeutic use
650	0	4	_aAngioplasty, Balloon, Coronary
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aCombined Modality Therapy
650	0	4	_aCoronary Disease _xcomplications
650	0	4	_aDrug Monitoring
650	0	4	_aEptifibatide
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aInfusions, Intravenous
650	0	4	_aMyocardial Infarction _xetiology
650	0	4	_aPatient Selection
650	0	4	_aPeptides _xtherapeutic use
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRecurrence
650	0	4	_aRisk Factors
650	0	4	_aTirofiban
650	0	4	_aTreatment Outcome
650	0	4	_aTyrosine _xanalogs & derivatives
700	1		_aCaliff, R M
700	1		_aTopol, E J
773	0		_tJournal of the American College of Cardiology _gvol. 35 _gno. 5 _gp. 1103-15
856	4	0	_uhttps://doi.org/10.1016/s0735-1097(00)00554-4 _zAvailable from publisher's website
999			_c10712268 _d10712268